Skip to content

Insider · CIK 0001867450

Gary J. Nabel

directorofficer

Files at OPK (OPKO HEALTH, INC.), SIGA (SIGA TECHNOLOGIES INC), CADL (Candel Therapeutics, Inc.). First filing -, latest -.

Gary J. Nabel files SEC Form 4 as director and officer at OPK (OPKO HEALTH, INC.), and also at SIGA (SIGA TECHNOLOGIES INC), CADL (Candel Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.

A track record needs three past buys with six months of prices behind them; Gary J. Nabel has 0, so none is measured yet.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold

Signals

This insider’s open-market buys and sells, scored.

No scored open-market trades yet.

Transactions

Every row this insider has filed, 8 in all, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Jun 23, 2026CADL
Candel Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+32,000$0.00$032,000Jun 24, 2026
Jun 25, 2025CADL
Candel Therapeutics, Inc.
AGrant or award
Common Stock
+5,353$4.67$25k5,353Jun 26, 2025
Jun 17, 2025CADL
Candel Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+14,240$0.00$014,240Jun 18, 2025
Jun 10, 2025SIGA
SIGA TECHNOLOGIES INC
MOption exercise
Common Stock, par value $.0001 per share
+19,084--62,598Jun 11, 2025
Jun 10, 2025SIGA
SIGA TECHNOLOGIES INC
DDisposition to issuer
Common Stock, par value $.0001 per share
-5,725$6.22$36k56,873Jun 11, 2025
Jun 10, 2025SIGA
SIGA TECHNOLOGIES INC
MOption exercise
Restricted Stock Unitsderivative
-19,084$0.00$00Jun 11, 2025
Jun 10, 2025SIGA
SIGA TECHNOLOGIES INC
AGrant or award
Restricted Stock Unitsderivative
+24,116$0.00$024,116Jun 11, 2025
May 27, 2025OPK
OPKO HEALTH, INC.
AGrant or award
Stock Option (Right to Buy)derivative
+437,500$0.00$0437,500May 29, 2025

Questions about Gary J. Nabel

Answered from the filings on this page, as of the latest one.

Is Gary J. Nabel buying or selling?

Gary J. Nabel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.

How did Gary J. Nabel's past buys perform?

Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gary J. Nabel has 0.

Where does Gary J. Nabel file Form 4?

Gary J. Nabel has filed Form 4 at OPK (OPKO HEALTH, INC.) as Chief Innovation Officer; SIGA (SIGA TECHNOLOGIES INC); CADL (Candel Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Gary J. Nabel: insider trades and track record | InsiderTell